Workflow
Cardinal Health(CAH)
icon
Search documents
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2025 on August 12
Prnewswire· 2025-07-15 10:45
Core Insights - Cardinal Health plans to release its fourth-quarter and year-end financial results for fiscal year 2025 on August 12, prior to the opening of trading on the New York Stock Exchange [1] - A webcast discussion of these results will begin at 8:30 a.m. Eastern on the same day [1] Access Information - The webcast and corresponding slide presentation can be accessed via Cardinal Health's Investor Relations page without the need for an access code [2] - Presentation slides and a replay of the webcast will be available on the Investor Relations page for 12 months [2] Company Overview - Cardinal Health is a distributor of pharmaceuticals and specialty products, a global manufacturer and distributor of medical and laboratory products, and a supplier of home-health and direct-to-patient products and services [3] - The company operates nuclear pharmacies and manufacturing facilities and provides performance and data solutions [3] - Cardinal Health emphasizes a customer-centric focus that drives continuous improvement and leads to innovative solutions that enhance people's lives [3]
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy
Prnewswire· 2025-07-11 12:30
DUBLIN, Ohio, July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists' advocacy efforts.  This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to ...
Is BioCryst Pharmaceuticals (BCRX) Outperforming Other Medical Stocks This Year?
ZACKS· 2025-07-07 14:41
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is BioCryst Pharmaceuticals (BCRX) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.BioCryst Pharmaceuticals is a member of our Medical group, which includes 987 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best ...
Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-07-01 17:01
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...
5 Must-Watch Stocks Favored by Brokers as 2H25 Begins
ZACKS· 2025-07-01 14:01
Market Overview - The first half of 2025 experienced increased volatility and uncertainty due to President Trump's tariffs and a faster-than-expected cooling of inflation, leading to market recovery [1] - Recent months have shown favorable market conditions with easing trade tensions and a reduction in the Middle East crisis [1] Stock Performance and Recommendations - Optimism regarding artificial intelligence is expected to continue supporting stock prices, particularly in technology sectors [2] - Cooling inflation raises expectations for potential rate cuts starting in September 2025, contributing to a positive market outlook [2] - Stocks such as Cracker Barrel Old Country Store (CBRL), BGSF, ArcBest Corporation (ARCB), Cardinal Health (CAH), and AutoNation (AN) are recommended for monitoring as the second half of 2025 begins [2][6] Screening Strategy - A screening strategy has been developed to identify stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks [3] - The price/sales ratio is included as a valuation metric, focusing on companies with strong top-line performance [3] Screening Criteria - The top 75 companies with net upgrades in broker ratings over the last four weeks are identified [4] - The top 10 stocks with the highest percentage change in earnings estimates for the upcoming quarter are highlighted [4] - Companies in the bottom 10% of price-to-sales ratios are included for better valuation [4] Company Highlights - Cracker Barrel is focusing on menu innovation and pricing strategies to drive growth, introducing new offerings to attract customers [5] - BGSF has seen a 25% increase in shares over the past month and has a Zacks Rank 1, with earnings estimates rising over 300% in the last 60 days [7] - ArcBest is improving productivity and service quality, expecting a 52.1% increase in earnings per share for 2026 compared to 2025 [8] - Cardinal Health is undergoing strategic improvements to revitalize its business model, with its Medical segment expected to drive growth [9][10] - AutoNation's diversified product portfolio and strategic acquisitions support its market position, currently holding a Zacks Rank 3 [11]
Cardinal Health (CAH) Laps the Stock Market: Here's Why
ZACKS· 2025-06-26 23:01
Group 1: Company Performance - Cardinal Health (CAH) closed at $165.61, with a daily increase of +1.14%, outperforming the S&P 500's gain of 0.8% [1] - Over the past month, CAH shares increased by 6.94%, surpassing the Medical sector's gain of 3.12% and the S&P 500's gain of 5.12% [1] Group 2: Upcoming Financial Results - The upcoming EPS for Cardinal Health is projected at $2.02, indicating a 9.78% increase year-over-year [2] - The Zacks Consensus Estimate for revenue is $60.65 billion, reflecting a 1.31% increase from the previous year [2] Group 3: Full Year Projections - For the full year, earnings are projected at $8.18 per share, representing an increase of +8.63%, while revenue is expected to be $223.07 billion, a decrease of -1.72% from the prior year [3] Group 4: Analyst Estimates and Stock Performance - Changes in analyst estimates for Cardinal Health are important as they reflect short-term business trends and analysts' confidence in performance [4] - The Zacks Rank system, which incorporates estimate changes, indicates Cardinal Health holds a Zacks Rank of 2 (Buy) [6] Group 5: Valuation Metrics - Cardinal Health has a Forward P/E ratio of 20.03, which is higher than the industry average of 17.14 [7] - The company has a PEG ratio of 1.83, compared to the industry average PEG ratio of 1.7 [8] Group 6: Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, holds a Zacks Industry Rank of 26, placing it in the top 11% of over 250 industries [9]
Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?
ZACKS· 2025-06-19 14:36
Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Cardinal Health (CAH), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like the Zacks Rank for making informed investment decisions [1][5][10]. Group 1: Brokerage Recommendations - Cardinal Health has an average brokerage recommendation (ABR) of 1.43, indicating a consensus between Strong Buy and Buy, based on recommendations from 14 brokerage firms [2]. - Out of the 14 recommendations, 11 are classified as Strong Buy, accounting for 78.6% of all recommendations [2]. - Despite the positive ABR, reliance solely on brokerage recommendations may not be prudent, as studies indicate limited success in guiding investors towards stocks with the highest price increase potential [5][10]. Group 2: Zacks Rank vs. ABR - The Zacks Rank is a proprietary stock rating tool that classifies stocks into five groups based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently and reflects changes in earnings estimates, making it a timely tool for predicting future price movements [12]. - Cardinal Health's Zacks Consensus Estimate for the current year has increased by 0.9% to $8.16, indicating growing optimism among analysts regarding the company's earnings prospects [13]. Group 3: Investment Implications - The recent change in the consensus estimate, along with other factors, has resulted in a Zacks Rank 2 (Buy) for Cardinal Health, suggesting a favorable outlook for the stock [14]. - The Buy-equivalent ABR for Cardinal may serve as a useful guide for investors when combined with the Zacks Rank [14].
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
ZACKS· 2025-06-16 14:45
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsid ...
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
ZACKS· 2025-06-13 14:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...
Cardinal Health (CAH) 2025 Investor Day Transcript
2025-06-12 14:00
Summary of Cardinal Health's 2025 Investor Day Company Overview - **Company**: Cardinal Health (CAH) - **Event**: 2025 Investor Day held on June 12, 2025 Key Industry Insights - **Healthcare Industry Role**: Cardinal Health positions itself as a crucial link in the healthcare supply chain, connecting manufacturers to patients through a complex distribution network [7][31] - **Market Trends**: The aging population and ongoing healthcare innovations are driving demand in the healthcare sector, providing a "rising tide" of volume for the industry [32] Core Business Strategies - **Core Distribution Focus**: The company emphasizes strengthening its core distribution business, which is foundational for future growth and profitability [19][20] - **Specialty Solutions Growth**: Specialty solutions remain the highest growth priority, with a focus on organic and inorganic investments in this segment [21][50] - **Investment in Automation**: Cardinal Health is investing in automation to enhance distribution efficiency and capacity, which is critical for meeting customer needs [13][40] Financial Performance and Guidance - **Earnings Growth**: The company raised its fiscal 2025 EPS guidance and confirmed a long-term EPS growth target of 12-14% for fiscal years 2026-2028 [27][55] - **Capital Deployment**: Over the past two years, Cardinal Health has returned nearly $3 billion to shareholders while also increasing capital expenditures by over 50% compared to four to five years ago [25][24] Specialty Solutions and Partnerships - **Specialty Alliance Formation**: The formation of the Specialty Alliance aims to enhance capabilities in gastroenterology, urology, and oncology, leveraging existing infrastructure and expertise [41][90] - **Managed Service Organizations (MSOs)**: The company is expanding its MSO platforms to support independent physicians, providing back-office support and enhancing care delivery [92] Innovations and Technology - **New Distribution Centers**: Cardinal Health is launching a new flagship distribution center with advanced automation technology to improve service levels and efficiency [40][69] - **Technology Investments**: Significant investments in technology infrastructure, including a new ordering platform (Vantas HQ), are aimed at improving customer experience and operational efficiency [70] Market Position and Competitive Advantage - **Diverse Customer Base**: The company serves a wide range of customers, including independent pharmacies, health systems, and specialty practices, allowing it to adapt to various market needs [64][65] - **Strategic Sourcing**: Strong relationships with brand manufacturers and partnerships with CVS enhance product availability and cost efficiency, contributing to profitable growth [66] Future Outlook - **Growth Opportunities**: Cardinal Health anticipates significant growth in its specialty segment, with expectations of doubling the number of supported products in the next three years [98][106] - **Resilience in Cash Flow**: The company has demonstrated strong cash flow resilience, with a consistent upward trend over long periods, indicating robust operational performance [36][37] Conclusion - **Commitment to Innovation**: Cardinal Health is focused on continuous improvement and innovation to meet evolving customer and patient needs, positioning itself for sustained growth in the healthcare industry [34][55]